Library/For Recovery/KPV

RUO · Research Use OnlyAnti-InflammatoryFor RecoveryTripeptide+2 more

KPV

A three-amino-acid fragment of alpha-MSH. We read all 36 studies. The protocol is below.

Updated 03 May 2026Read 10 minEvidence ●●○○○Citations 36

+ Add to Stack⚖ Compare

⚖ Compare side-by-side ⎙ Print companion card

Free — puts KPV on your decision board.

The KPV Report · $19

Everything you need to start: dose, sourcing, safety, our verdict.

One purchase · yours forever

Built from 36 cited studies.

Status

Research-only

Class

Anti-Inflammatory

Evidence

2/ 5●●○○○

Randomized human trials

$19 ↓

Open-label / case reports

$19 ↓

Animal colitis studies

$19 ↓

Read this if

you have mild IBD and your GI hasn't approved adjunctive peptides but your gut still hurts
you're already on BPC-157 oral and want a less-hyped second peptide
you're in the functional-medicine "leaky gut" cohort and want to know what's real and what isn't

Skip this if

**you're being told you have 'leaky gut' by a functional-medicine practitioner without a GI workup.** Leaky gut is not a validated diagnosis on its own — the right move is a real GI evaluation (rule out celiac, IBD, microscopic colitis, SIBO, infection, food intolerance) before you treat the label. KPV won't fix a missed celiac diagnosis or an undiagnosed Crohn's, and a 'leaky gut' label without a workup is the wrong door to walk through to buying it
you want randomized human data — there isn't any yet
you have active autoimmune skin disease (rosacea, vitiligo, melanocyte disorders)
you have a melanocortin-system disorder or recent melanoma history

The 4 ways you can buy KPV

No FDA-approved KPV exists.

Compounded 503A

⚠

$80–$200/mo where still sold

Compounders shipping under contested legal interpretations.

RUO (research-only)

✓

Sold 'for research only'

$25–$70/mo

The dominant supply. KPV is small (tripeptide) and cheap to synthesize.

Gray market

✓

Unregulated overseas import

~$10/mo

Crypto/Wise pay, no published COA; minimum order is one box of 10×10mg.

Click any lane for the full Sourcing breakdown. Prices and lane availability vary by molecule — this is the per-peptide snapshot, not a generic table.

First 90 days · KPV

What we'd actually do

Weeks 1–2

Nothing perceptible. The healing-acceleration effect — if it's going to work — isn't a week-one signal. If you 'feel something' immediately, that's expectation, not the peptide.

Weeks 4–8

Subtle improvement on the target injury if it's going to work. Range of motion, less morning stiffness, less acute pain on load.

Week 12 — decide

Honest decision point. Either the injury is materially better than the no-peptide trajectory would have been, or it isn't. The clinical literature in humans is thin enough that your n=1 trial IS the evidence base.

Quit if

Any unusual symptoms — especially relevant if you have a personal or family cancer history (angiogenesis mechanism for BPC-157, TB-500).
12 weeks with no perceived improvement vs the no-peptide trajectory.
New pain or symptoms at injection site that don't resolve in 48 hours.

Identity

What it is.

KPV is a three-amino-acid fragment (lysine-proline-valine) of alpha-MSH, a hormone better known for its role in pigmentation. The fragment doesn't have the pigmentary effect of the parent molecule. What it does have, in cell and animal models, is anti-inflammatory activity — specifically dampening the NF-κB pathway that drives a lot of mucosal inflammation.

It's typically used for gut inflammation: IBD-adjacent symptoms, ulcerative colitis-style flares, occasionally skin inflammation in topical form. The most common route is oral (where it's absorbed across the gut mucosa) or topical, less commonly .

It's sold strictly as a research chemical (RUO) in the US. There is no form. There is no recognized clinical indication. It survives commercially because patients with treatment-resistant gut symptoms keep finding it.

TL;DR

TL;DR. 30-second version.

The compressed verdict — what KPV actually is, what the human evidence shows, and the watch-for in three bullets. Locked.

Get the report · $19 ↓

Mechanism

Mechanism.

Mechanism · in the KPV report

How the molecule actually works — receptor profile, downstream signaling, what to expect mechanistically.

Get the report · $19 ↓

Evidence

Evidence. What we actually know in humans.

Evidence · in the KPV report

The trial breakdown — phase, n, primary endpoint, who funded, what hit, what didn't.

Get the report · $19 ↓

Human-Evidence Factbox

Randomized human trials

$19 ↓

Open-label / case reports

$19 ↓

Animal colitis studies

$19 ↓

Route with published evidence

Oral (PepT1 absorption)

Years of off-label use

$19 ↓

Major adverse events flagged

$19 ↓

Mechanism

$19 ↓

'Leaky gut' as a standalone diagnosis

$19 ↓

Melanocortin / melanoma mechanism concern

$19 ↓

Dose

Dose. The actual protocol.

Dose · in the KPV report

The specific protocol — dose, titration schedule, cycle pattern, frequency, route.

We read 36 studies to write this report.

Get the report · $19 ↓

Sourcing

Sourcing. Where the cohort actually buys.

Sourcing · in the KPV report

Sourcing breakdown — vendor methodology, red flags, our published test results, COA checklist.

We read 36 studies to write this report.

Get the report · $19 ↓

Safety

Safety. Side effects.

Safety · in the KPV report

The watch-for list — contraindications, drug interactions, monitoring labs, when to stop.

Get the report · $19 ↓

Editorial Position

Editorial position.

Editorial Position · in the KPV report

Our editorial position — explicit yes / no / depends, with the reasoning behind it.

Get the report · $19 ↓

Citations

Citations.

+Show all 36 citations

The KPV Report · $19

Everything you need to start.

Dose, sourcing, safety, our verdict. One purchase. Yours forever.

Built from 36 cited studies.

Or get every report. All reports — $99 once · Pro — $29/mo.

Compare tiers →